William C Goedel1, Maximilian R F King1, Mark N Lurie1, Sandro Galea2, Jeffrey P Townsend3,4,5, Alison P Galvani3,4,6, Samuel R Friedman7, Brandon D L Marshall1. 1. Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island. 2. Department of Epidemiology, School of Public Health, Boston University, Massachusetts. 3. Department of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut. 4. Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut. 5. Department of Biostatistics, School of Public Health, Yale University, New Haven, Connecticut. 6. Center for Infectious Disease Modeling and Analysis, School of Public Health, Yale University, New Haven, Connecticut. 7. National Development and Research Institutes, Inc, New York, New York.
Abstract
BACKGROUND: Syringe services programs (SSPs) are effective venues for delivering harm-reduction services to people who inject drugs (PWID). However, SSPs often face significant barriers to implementation, particularly in the absence of known human immunodeficiency virus (HIV) outbreaks. METHODS: Using an agent-based model, we simulated HIV transmission in Scott County, Indiana, a rural county with a 1.7% prevalence of injection drug use. We compared outcomes arising in the absence of an SSP, in the presence of a pre-existing SSP, and with implementation of an SSP after the detection of an HIV outbreak among PWID over 5 years following the introduction of a single infection into the network. RESULTS: In the absence of an SSP, the model predicted an average of 176 infections among PWID over 5 years or an incidence rate of 12.1/100 person-years. Proactive implementation averted 154 infections and decreased incidence by 90.3%. With reactive implementation beginning operations 10 months after the first infection, an SSP would prevent 107 infections and decrease incidence by 60.8%. Reductions in incidence were also observed among people who did not inject drugs. CONCLUSIONS: Based on model predictions, proactive implementation of an SSP in Scott County had the potential to avert more HIV infections than reactive implementation after the detection of an outbreak. The predicted impact of reactive SSP implementation was highly dependent on timely implementation after detecting the earliest infections. Consequently, there is a need for expanded proactive SSP implementation in the context of enhanced monitoring of outbreak vulnerability in Scott County and similar rural contexts.
BACKGROUND: Syringe services programs (SSPs) are effective venues for delivering harm-reduction services to people who inject drugs (PWID). However, SSPs often face significant barriers to implementation, particularly in the absence of known human immunodeficiency virus (HIV) outbreaks. METHODS: Using an agent-based model, we simulated HIV transmission in Scott County, Indiana, a rural county with a 1.7% prevalence of injection drug use. We compared outcomes arising in the absence of an SSP, in the presence of a pre-existing SSP, and with implementation of an SSP after the detection of an HIV outbreak among PWID over 5 years following the introduction of a single infection into the network. RESULTS: In the absence of an SSP, the model predicted an average of 176 infections among PWID over 5 years or an incidence rate of 12.1/100 person-years. Proactive implementation averted 154 infections and decreased incidence by 90.3%. With reactive implementation beginning operations 10 months after the first infection, an SSP would prevent 107 infections and decrease incidence by 60.8%. Reductions in incidence were also observed among people who did not inject drugs. CONCLUSIONS: Based on model predictions, proactive implementation of an SSP in Scott County had the potential to avert more HIV infections than reactive implementation after the detection of an outbreak. The predicted impact of reactive SSP implementation was highly dependent on timely implementation after detecting the earliest infections. Consequently, there is a need for expanded proactive SSP implementation in the context of enhanced monitoring of outbreak vulnerability in Scott County and similar rural contexts.
Authors: Alex H Kral; Kimberly Page-Shafer; Brian R Edlin; Timothy Kellogg; Elise Riley; Lauren Gee; Andrew Moss; Michael Busch; Jeffrey D Klausner; James Dilley; Willi McFarland Journal: J Acquir Immune Defic Syndr Date: 2004-12-15 Impact factor: 3.731
Authors: Jonathan A C Sterne; Miguel A Hernán; Bruno Ledergerber; Kate Tilling; Rainer Weber; Pedram Sendi; Martin Rickenbach; James M Robins; Matthias Egger Journal: Lancet Date: 2005 Jul 30-Aug 5 Impact factor: 79.321
Authors: Jacek Skarbinski; Eli Rosenberg; Gabriela Paz-Bailey; H Irene Hall; Charles E Rose; Abigail H Viall; Jennifer L Fagan; Amy Lansky; Jonathan H Mermin Journal: JAMA Intern Med Date: 2015-04 Impact factor: 21.873
Authors: Richard A Crosby; Carrie B Oser; Carl G Leukefeld; Jennifer R Havens; April Young Journal: Ann Epidemiol Date: 2012-08-14 Impact factor: 3.797
Authors: Philip J Peters; Pamela Pontones; Karen W Hoover; Monita R Patel; Romeo R Galang; Jessica Shields; Sara J Blosser; Michael W Spiller; Brittany Combs; William M Switzer; Caitlin Conrad; Jessica Gentry; Yury Khudyakov; Dorothy Waterhouse; S Michele Owen; Erika Chapman; Jeremy C Roseberry; Veronica McCants; Paul J Weidle; Dita Broz; Taraz Samandari; Jonathan Mermin; Jennifer Walthall; John T Brooks; Joan M Duwve Journal: N Engl J Med Date: 2016-07-21 Impact factor: 91.245
Authors: Louisa Degenhardt; Amy Peacock; Samantha Colledge; Janni Leung; Jason Grebely; Peter Vickerman; Jack Stone; Evan B Cunningham; Adam Trickey; Kostyantyn Dumchev; Michael Lynskey; Paul Griffiths; Richard P Mattick; Matthew Hickman; Sarah Larney Journal: Lancet Glob Health Date: 2017-10-23 Impact factor: 26.763
Authors: Magdalena Cerdá; Mohammad S Jalali; Ava D Hamilton; Catherine DiGennaro; Ayaz Hyder; Julian Santaella-Tenorio; Navdep Kaur; Christina Wang; Katherine M Keyes Journal: Epidemiol Rev Date: 2022-01-14 Impact factor: 6.222
Authors: Xiao Zang; Williams C Goedel; Sam E Bessey; Mark N Lurie; Sandro Galea; Alison P Galvani; Samuel R Friedman; Bohdan Nosyk; Brandon D L Marshall Journal: AIDS Date: 2022-02-24 Impact factor: 4.632
Authors: Jared L Sawyer; Shikhar Shrestha; Jennifer C Pustz; Robert Gottlieb; Deborah Nichols; Michelle Van Handel; Cailyn Lingwall; Thomas J Stopka Journal: Prev Med Rep Date: 2021-08-27
Authors: Jesse L Yedinak; Yu Li; Maxwell S Krieger; Katharine Howe; Colleen Daley Ndoye; Hyunjoon Lee; Anna M Civitarese; Theodore Marak; Elana Nelson; Elizabeth A Samuels; Philip A Chan; Thomas Bertrand; Brandon D L Marshall Journal: Int J Drug Policy Date: 2021-07-31